newsfilter
← Latest News
GlobeNewswire·

Plus Therapeutics Reports Third Quarter Financial Results and Recent Business Highlights

US market introduction of the CNSide® CSF diagnostics platform, with first national coverage agreement with UnitedHealthcare Presented positive RESPECT-LM Ph1 clinical trial results HOUSTON, Oct. 30, 2025 (GLOBE